阻害性睡眠時無呼吸症の治療がHIVの一般的な症状に及ぼす影響
David L Berry1, Jeremy E Orr1, Christopher N Schmickl1
1University of California San Diego, Division of Pulmonary Critical Care and Sleep Medicine, La Jolla, CA.
Journal of acquired immune deficiency syndromes (1999)
|August 26, 2025
まとめ
HIV感染者における阻害性睡眠無呼吸症 (OSA) の治療は,呼吸道圧縮療法 (PAP) により,疲労と心血管の健康指標を改善します. これは,PLWHにおけるOSAの評価と治療の重要性を強調しています.
科学分野:
- 睡眠医学
- 心臓病科
- 感染症 (HIV/エイズ)
背景:
- HIV感染者 (PLWH) はしばしば疲労と心血管疾患のリスクの増加を経験します.
- 阻害性睡眠無呼吸症候群 (OSA) はPLWHにおいて一般的であり,これらの健康問題にも寄与する可能性があります.
- PLWHにおけるOSA治療の効果は,まだ十分に研究されていない.
研究 の 目的:
- HIV感染者 (PLWH) でOSAを患っている患者の疲労と心血管の健康に対するプラスの気道圧 (PAP) 療法の効果を調査する.
- OSA治療後の睡眠の質,昼間の眠気,および認知機能の変化を評価する.
主な方法:
- 120人のPLWHはポリソムノグラフィーを受け,検証されたアンケートに記入した.
- OSAを患った被験者には,呼吸道圧力の改善療法 (PAP) を12週間提供した.
- 心血管指標 (RHI,心拍数,血圧) と患者の報告したアウトカムが治療後再評価されました.
主要な成果:
- OSAの70人の参加者のうち41人がPAP療法を使用しました.
- PAP治療は疲労,反応性高血症指数 (RHI),心拍数 (p<0. 05) を有意に改善した.
- 日中の眠気,睡眠の質,認知機能の改善も観察されましたが,変化は控えめでした.
結論:
- 陽性呼吸圧 (PAP) 療法は,OSAのHIV感染者 (PLWH) の疲労と心血管の健康指標を効果的に改善します.
- この結果は,PLWH以外の集団で見られた結果と一致し,PAP治療の有効性を支持しています.
- 一般的な症状を管理し,健康状態を改善するために,PLWHの評価と治療を考慮する必要があります.
さらに関連する動画
関連する概念動画
Sleep Apnea
220
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
220
Other Pulmonary Disorders
906
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
906
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K


